This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Bjoern Duesenberg: Innovator in Pharmaceutical Formulations
Introduction
Bjoern Duesenberg is a notable inventor based in Spardorf, Germany. He has made significant contributions to the field of pharmaceutical formulations. His innovative approach has led to the development of a unique process that enhances the efficacy of pharmaceutical products.
Latest Patents
Duesenberg holds a patent for a process for producing a pharmaceutical formulation comprising an active substance, polymer, and surfactant. This patent outlines a method that includes suspending a pharmaceutical active substance in an aqueous solution of a polymer and drying the mixture. The active substance is present in the form of particles with a size distribution of ≤1 μm, and it is further treated with an ionic surfactant before the drying step. This innovative process aims to improve the delivery and effectiveness of pharmaceutical formulations. He has 1 patent to his name.
Career Highlights
Bjoern Duesenberg is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to focus on developing advanced pharmaceutical solutions that address various health challenges.
Collaborations
Duesenberg has collaborated with esteemed colleagues such as Michael Ostendorf and Werner Hoheisel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Bjoern Duesenberg's contributions to pharmaceutical formulations exemplify the impact of innovative thinking in the healthcare industry. His patented process represents a significant advancement in the field, showcasing the importance of research and collaboration in developing effective pharmaceutical solutions.